PathoGenetix grabs $10 mln in Series C financing
PathoGenetix has raised $10 million in Series C financing. Return backers Ascension Health Ventures, Excel Venture Management and HealthCare Ventures participated in the round. Based in Woburn, Mass., PathoGenetix is a provider of rapid bacterial identification solutions.
30 October 2013•4 mins read
